JPRN-UMIN000004389已完成1 期
PhaseI/II clinical study of peptide vaccine against advanced or recurrent gastric cancer - PhaseI/II clinical study of peptide vaccine against advanced or recurrent gastric cancer
Department of Gastroenterological Surgery,Graduate School of Medicine,Osaka University0 个研究点目标入组 30 人开始时间: 2010年10月18日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Pregnancy Uncontrolled infection Patients with serious concomitant disease
研究者
相似试验
已完成
2 期
Phase II clinical trial of peptide vaccination with HLA-A2402-restricted KIF20A and VEGFR1 epitope peptides with gemcitabine chemotherapy in patients with unresectable advanced pancreatic cancerpancreatic cancerJPRN-UMIN000004641Department of Gastroenterology Juntendo University School of Medicine40
已完成
1 期
Phase I clinical study of peptide vaccine using novel tumor-associated antigen TTK against advanced esophageal carcinomaAdvanced esophageal cancer refractory to standard therapeutic modalityJPRN-UMIN000001014niversity of Tokyo6
已完成
1 期
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent pancreatic cancer to be refractory to chemotherapy by using new tumor antigen KIF20A and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiopancreatic cancerJPRN-UMIN000002022Department of Gastroenterology, Juntendo University School of Medicine36
已完成
1 期
Phase I / II clinical trial of peptide vaccination therapy for unresectable / recurrent gastric cancer to be refractory to chemotherapy by using new tumor antigen URLC10 and A2402 restrictive epitope peptide of the VEGFR1 origin related gene of tumor vascularizatiogastric cancerJPRN-UMIN000002409Department of Gastroenterology, Juntendo University School of Medicine36
已完成
1 期
Phase II study of peptide vaccination for patients with metastatic lung or gastro-intestinal tract cancerslung cancer, pharyngeal cancer, gastric cancer, jejunal cancer, ileal cancer, pancreas cancer, biliary tract cancer, soft tissue sarcomaJPRN-UMIN000002857Tohoku University Hospital14